Ociperlimab Clinical Trials Development Insight Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- PD-1 and CTLA-4 were the first immune checkpoints that were used as therapeutic targets by drug makers. Years later, a new generation of immune checkpoint...